Company: LIMN
Filing Date: 2025-06-24
Form Type: S-1
Source: 0001410578-25-001432
Chunk: 195

Company: Liminatus Pharma, Inc.
Filing Date: 2025-06-24
Form: S-1
Chunk 195
---
 
 F-54 |
|:----------------------------------------------------------------------------------------------------------------------|:-----|
| Unaudited Condensed Statements of Changes in Stockholders’ Deficit for the three months ended March 31, 2025 and 2024 | F-55 |
| Unaudited Condensed Statements of Cash Flows for the three months ended March 31, 2025 and 2024                       | F-56 |
| Notes to Unaudited Condensed Financial Statements                                                                     | F-57 |

| ​                                                                                             | ​    |
| Audited Financial Statements of Iris Acquisition Corp                                         | ​    |
| Report of Independent Registered Public Accounting Firm (PCAOB ID 688)                        | F-77 |
| Balance Sheets as of December 31, 2024 and 2023                                               | F-78 |
| Statements of Operations for the years ended December 31, 2024 and 2023                       | F-79 |
| Statements of Changes in Stockholders’ Deficit for the years ended December 31, 2024 and 2023 | F-80 |
| Statements of Cash Flows for the years ended December 31, 2024 and 2023                       | F-81 |
| Notes to Financial Statements                                                                 | F-82 |

F-1

Liminatus Pharma, Inc. (Succesor to Iris Parent Holding Corp.) Condensed Consolidated Balance Sheets

| ​                                                                                                                                      
 ​                                                                                                                                      
 ​                                                                                                                                      
 ​                                                                                                                                      
 Assets                                                                                                                                 
 Total Assets                                                                                                                           
 ​                                                                                                                                      
 Liabilities and stockholder’s deficit                                                                                                  
 Current liabilities:                                                                                                                   | ​ 
 ​ 
 ​ 
 ​ 
 ​ 
 ​ 
 ​ | ​           
 March 31,   
 2025        
 (Unaudited) 
 ​           
 ​           
 ​           
 ​           |      ​ 
      — 
      ​ 
      ​ 
      ​ | ​ 
 ​ 
 ​ 
 ​ 
 ​ 
 ​ 
 ​ | ​            
 December 31, 
 2024         
 ​            
 ​            
 ​            |    ​ 
    ​ 
    — 
    ​ |
|:---------------------------------------------------------------------------------------------------------------------------------------|:--|:------------|-------:|:--|:-------------|-----:|
| Accrued expenses                                                                                                                       | ​ | $           |  1,060 | ​ | $            |  805 |
| Total liabilities                                                                                                                      | ​ |             |  1,060 | ​ |              |  805 |
| Commitments and Contingencies (Note 4